Using homeostatic peptides in decompensated heart failure a reasonable paradigm but a flawed practice?
Silver
Marc A
MA
Yancy
Clyde W
CW
D058186:Acute Kidney Injury / Q000097:blood / Q000188:drug therapy*; D000368:Aged; D003404:Creatinine / Q000097:blood; D004311:Double-Blind Method; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006706:Homeostasis / Q000187:drug effects*; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D017211:Treatment Failure
D020097:Natriuretic Peptide, Brain; D003404:Creatinine